To determine the safety and efficacy of sub-antimicrobial dose COL-101 in the treatment of patients who have both blepharitis and facial rosacea
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
70
40mg, once per day for 84 days
sugar capsule
Pleasant Valley Ophthalmology
Little Rock, Arkansas, United States
Warren Scherer, MD
Naples, Florida, United States
Kentucky Lions Eye Center
Louisville, Kentucky, United States
Washington University School of Medicine
St Louis, Missouri, United States
Change in Bulbar Conjunctival Hyperemia
Bulbar conjunctival hyperemia will be assessed using an ordered categorical value ranging from 0 (Clear) to 4 (Severe). Hyperemia is graded on the following scale and half scores are acceptable: None (0) = normal Mild (1) = slight localized injection Moderate (2) = pink color Severe (3) = red color Very Severe (4) = marked dark redness
Time frame: Baseline to Week 12
Change in Ocular Surface Disease Index (OSDI)
OSDI is calculated based following formula using 12-question Ocular Surface Disease questionnaire (with each question scored 0-4): OSDI = (D/E)x25, where D = Sum of all scores for questions answered E = Total number of questions answered (not including questions answered NA) Range of OSDI is 0 to 100 (higher score indicates worse condition).
Time frame: Baseline to Week 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Marguerite McDonald, MD
Lynbrook, New York, United States
Dean McGee Eye Institute
Oklahoma City, Oklahoma, United States
Anita Nevyas-Wallace, MD
Bala-Cynwyd, Pennsylvania, United States
Tanner Clinic
Layton, Utah, United States